Moreover, the acquisition of APC mutations is considered an early event in the emergence of CRC, and secondary mutations in genes such as KRAS, P53 and SMAD4 contribute to driving carcinogenesis (Drost et al.,2015); such mutations may modulate the TNKSi response, although this remains speculative. Here, APC is linked to colorectal carcinoma.